​

Vera Therapeutics (VERA) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

VERA Stock Forecast

Vera Therapeutics (VERA) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $87.14, with a high of $125.00 and a low of $43.00. This represents a 139.72% increase from the last price of $36.35.

- $30 $60 $90 $120 $150 High: $125 Avg: $87.14 Low: $43 Last Closed Price: $36.35

VERA Stock Rating

Vera Therapeutics stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 1 Strong Buy (7.14%), 12 Buy (85.71%), 1 Hold (7.14%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 12 1 Strong Sell Sell Hold Buy Strong Buy

VERA Price Target Upside V Benchmarks

TypeNameUpside
StockVera Therapeutics139.72%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts4712
Avg Price Target$92.25$87.14$83.17
Last Closing Price$36.35$36.35$36.35
Upside/Downside153.78%139.72%128.80%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 261121--14
Jun, 261121--14
May, 261121--14
Apr, 261121--14
Mar, 261112--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 08, 2026Wedbush$43.00$42.960.09%18.29%
Jul 08, 2026Vamil DivanGuggenheim$76.00$42.9676.91%109.08%
Jul 08, 2026Needham$125.00$42.96190.97%243.88%
Jul 08, 2026H.C. Wainwright$125.00$42.96190.97%243.88%
Jun 02, 2026Farzin HaqueJefferies$60.00$31.2691.94%65.06%
Jun 02, 2026Paul ChoiGoldman Sachs$90.00$32.14180.02%147.59%
May 15, 2026Evercore ISI$91.00$38.54136.12%150.34%
Dec 19, 2025Goldman Sachs$95.00$47.6999.20%161.35%
Dec 11, 2025Laura ChicoWedbush$33.00$45.42-27.34%-9.22%
Dec 08, 2025Gavin Clark-GartnerEvercore ISI$97.00$45.79111.84%166.85%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 08, 2026Cowen & Co.BuyBuyhold
Jul 08, 2026WedbushNeutralNeutralhold
Jul 08, 2026GuggenheimBuyBuyhold
Jul 08, 2026H.C. WainwrightBuyBuyhold
Jun 02, 2026JefferiesBuyBuyhold
Jun 02, 2026William BlairOutperformOutperformhold
Jun 02, 2026Wolfe ResearchOutperformOutperformhold
Jun 02, 2026Goldman SachsBuyBuyhold
Jun 02, 2026Raymond JamesStrong BuyStrong Buyhold
Jun 02, 2026Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.25$-2.75$-4.66---
Avg Forecast$-2.18$-2.83$-3.15$-3.04$-2.07$0.86
High Forecast$-2.11$-2.65$-2.23$-2.06$-0.09$0.86
Low Forecast$-2.26$-2.99$-4.73$-4.16$-3.80$0.86
Surprise %3.21%-2.83%47.94%---

Revenue Forecast

$0 $110M $220M $330M $440M $550M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast$1.86M$1.86M$1.86M$42.58M$210.59M$516.01M
High Forecast$1.86M$1.86M$1.86M$42.58M$210.59M$516.01M
Low Forecast$1.86M$1.86M$1.86M$42.58M$210.59M$516.01M
Surprise %------

Net Income Forecast

$-300M $-230M $-160M $-90M $-20M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-95.99M$-152.15M$-299.62M---
Avg Forecast$-95.99M$-120.50M$-148.70M$-133.00M$-154.25M$36.57M
High Forecast$-90.22M$-113.19M$-95.27M$-88.17M$-4.04M$36.57M
Low Forecast$-96.57M$-127.81M$-202.13M$-177.82M$-162.30M$36.57M
Surprise %-26.26%101.48%---

VERA Forecast FAQ

Is Vera Therapeutics stock a buy?

Vera Therapeutics stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 12 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Vera Therapeutics is a favorable investment for most analysts.

What is Vera Therapeutics's price target?

Vera Therapeutics's price target, set by 14 Wall Street analysts, averages $87.14 over the next 12 months. The price target range spans from $43 at the low end to $125 at the high end, suggesting a potential 139.72% change from the previous closing price of $36.35.

How does Vera Therapeutics stock forecast compare to its benchmarks?

Vera Therapeutics's stock forecast shows a 139.72% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Vera Therapeutics over the past three months?

  • July 2026: 7.14% Strong Buy, 85.71% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 7.14% Strong Buy, 85.71% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 7.14% Strong Buy, 85.71% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.

What is Vera Therapeutics’s EPS forecast?

Vera Therapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $-3.04, marking a -34.76% decrease from the reported $-4.66 in 2025. Estimates for the following years are $-2.07 in 2027, and $0.86 in 2028.

What is Vera Therapeutics’s revenue forecast?

Vera Therapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $42.58M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $210.59M, and $516.01M for 2028.

What is Vera Therapeutics’s net income forecast?

Vera Therapeutics's net income forecast for the fiscal year ending in December 2026 stands at $-133M, representing a -55.61% decrease from the reported $-300M in 2025. Projections indicate $-154M in 2027, and $36.57M in 2028.